Patent · US Active

Binding proteins to the human thrombin receptor, PAR4

US11780915B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

MONASH UNIVERSITY · AU

Inventors

Justin David Hamilton · Wellington, NZ
Mark Sleeman · New York, US

Key dates

Filing date	Sep 11, 2018
Grant date	Oct 10, 2023
Priority date	—
Expiry date	Oct 8, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to human protease activated receptor 4 (PAR4) binding proteins (e.g. antibodies). In particular, anti-PAR4 binding proteins which are antagonists of human PAR4, as well as methods and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.